TOP STORIES

• REGULATORY Japan OKs Honebuto Budget Policy Blueprint, Vows Debates on Longer-Term Drug Costs
  June 19, 2023

• BUSINESS As Wholesalers Try to Negotiate Higher Prices, Hospitals Face Tougher Haggling This Year
  June 16, 2023

• ORGANIZATION Lag and Loss Blamed on Drug Pricing System, JPMA Set to Get Involved in Corrective Steps: President
  June 15, 2023

• BUSINESS AstraZeneca Launches Sales Unit Dedicated to GI Cancer as Imfinzi Expands Label
  June 14, 2023

• REGULATORY LDP Policy Research Council Generally Approves Revised Honebuto Draft
  June 14, 2023

• REGULATORY MHLW Publishes Final Report by Expert Panel on Comprehensive Pharma Policy
  June 13, 2023

• ORGANIZATION Tide Has Changed, but That Doesn’t Erase Concerns: FPMAJ Drug Pricing Chief
  June 12, 2023

• BUSINESS AstraZeneca Crowned in Foreign Pharma Ranking for 2nd Year Straight, Followed by MSD
  June 9, 2023

• REGULATORY Honebuto Social Security Debate Culminates with LDP Push for Nixing Budget Cap
  June 9, 2023

• REGULATORY Sumitomo to Urge Switch from Noritren over Carcinogen Risks, but Continues Shipments
  June 8, 2023

• REGULATORY Draft Honebuto Paper Unveiled, Cabinet OK Expected in Mid-June
  June 8, 2023

• REGULATORY Draft Honebuto Paper Calls for Further Drug Pricing Measures to Reward Innovation
  June 7, 2023

• ORGANIZATION Industry’s Concerns Beginning to Sink in among Policymakers: JPMA Committee Chair
  June 7, 2023

• BUSINESS Japan Firms Joining Fray in siRNA Drug Development; Takeda Could File as Early as FY2025
  June 6, 2023

• REGULATORY Expert Panel to Propose Setting Up Requirements for Generic Entry to Ensure Stable Supplies; Draft Report Due Out June 6
  June 5, 2023

• REGULATORY Expert Panel Pushes Fresh Evaluation Approach for New Drug Pricing, Rethink of Spillovers: Draft Report
  June 5, 2023

• BUSINESS Shionogi Shoots for Doubling Revenue to 800 Billion Yen by FY2030
  June 2, 2023

• BUSINESS Pharma Companies in Japan Raising Retirement Age, Extending Rehiring: Jiho Poll
  June 1, 2023

• BUSINESS AbbVie Aims to Double Japan Sales to 200 Billion Yen by 2030: Local Chief
  May 31, 2023

• REGULATORY Japan to Launch New Forum to Spur Secondary Use of Medical Data in Drug Discovery
  May 30, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 59
• 60
• 61
• 62
• 63
• 64
• 65
• 66
• 67
• …
• Next ›
• 最終 »